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Abstract. 
 
Chemoattractants differ in their capacity to 
stimulate neutrophils to adhere to and to migrate 
through matrices containing ﬁbrin. Formyl methionyl 
leucyl phenylalanine (fMLP) stimulates neutrophils to 
adhere closely to, but not to migrate into, ﬁbrin gels. 
Leukotriene B4 (LTB4) stimulates neutrophils to ad-
here loosely to and to migrate through ﬁbrin gels. We 
report that 
 
a
 
5
 
b
 
1 
 
integrins regulate the different migra-
tory behaviors on ﬁbrin gels of neutrophils in response 
to these chemoattractants. fMLP, but not LTB4, acti-
vated neutrophil 
 
b
 
1 
 
integrins, as measured by binding of 
mAb 15/7 to an activation epitope on the 
 
b
 
1
 
 integrins. 
Antibodies or peptides that block 
 
a
 
5
 
b
 
1
 
 integrins pre-
vented fMLP-stimulated neutrophils from forming 
zones of close apposition on ﬁbrin and reversed fMLP’s 
inhibitory effect on neutrophil chemotaxis through ﬁ-
brin. In contrast, neither peptides nor antibodies that 
block 
 
b
 
1
 
 integrins affected the capacity of LTB4-stimu-
lated neutrophils to form zones of loose apposition or 
to migrate through ﬁbrin gels. These results suggest that 
chemoattractants generate at least two different mes-
sages that direct neutrophils, and perhaps other leuko-
cytes, to accumulate at speciﬁc anatomic sites: a general 
message that induces neutrophils to crawl and a speciﬁc 
message that prepares neutrophils to stop when they 
contact appropriate matrix proteins for activated 
 
b
 
1
 
 in-
tegrins.
Key words: chemotaxis • neutrophils • integrins • ﬁ-
brin • chemoattractants
 
L
 
EUKOCYTE
 
 chemotaxis is regulated by the interactions
of soluble or surface-bound chemoattractants/che-
mokines with cognate receptors on the leukocytes.
These interactions generate intracellular signals that acti-
vate one or more of the leukocyte’s adhesion-promoting
receptors, thereby enabling these cells to adhere to or mi-
grate through endothelia, epithelia, and extracellular ma-
trices.
Neutrophils (polymorphonuclear leukocytes, PMN)
 
1
 
 ex-
press a number of different adhesion-promoting surface
receptors, including 
 
b
 
1
 
 and 
 
b
 
2 
 
integrins. 
 
b
 
2
 
 integrins as-
sume an “activated” conformation when chemoattrac-
tants, chemokines, cytokines, or growth factors bind to
specific receptors for these substances on PMN (Diamond
and Springer, 1994; Premack and Schall, 1996). Activation
increases the capacity of 
 
b
 
2
 
 integrins to bind cognate
ligands on cells or matrix proteins, thereby regulating
PMN adhesion to and migration through endothelia (Smith,
1993; Springer, 1995), epithelia (McCormick et al., 1995),
layers of synovial fibroblasts (Gao et al., 1995; Gao and Is-
sekutz, 1996), and extracellular matrices (Wright et al., 1988;
Loike et al., 1991, 1992, 1995). The central roles played by
 
b
 
2
 
 integrins in PMN adhesion and chemotaxis in vivo are
illustrated by the multiple derangements of PMN function
in humans with the inherited disorder leukocyte adhesion
deficiency type 1, in which there is partial to complete ab-
sence of 
 
b
 
2
 
 chains (Anderson and Springer, 1987), and in
mice rendered functionally or genetically deficient in 
 
a
 
M
 
b
 
2
 
(CD11b/CD18) integrin (Tang et al., 1997).
PMN also express 
 
b
 
1
 
 integrins, primarily 
 
a
 
3
 
b
 
1
 
, 
 
a
 
5
 
b
 
1
 
, and
 
a
 
6
 
b
 
1
 
, but also very low levels of 
 
a
 
4
 
b
 
1 
 
(Gao et al., 1995;
Gresham et al., 1996) that participate in PMN adhesion,
migration, and phagocytosis. For example, C5a, a cleavage
product of the fifth component of complement, and PMA
stimulate 
 
a
 
5
 
b
 
1
 
-dependent PMN adherence to fibronectin
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Abbreviations used in this paper:
 
 C3bi, cleaved b fragment of the 3rd
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serum albumin; IL-8, interleukin 8; LTB4, leukotriene B4; PMN, poly-
morphonuclear leukocytes; Rh-PEG, rhodamine-conjugated polyethylene
glycol. 
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(Bohnsack et al., 1995). Chemoattractant-activated 
 
b
 
1
 
 in-
tegrins work in concert with 
 
a
 
M
 
b
 
2
 
 (CD11b/CD18) inte-
grins to mediate phagocytosis of particles coated with C3bi
by PMN (Pommier et al., 1983; Wright et al., 1984; Brown,
1992). 
 
b
 
1
 
 integrins also mediate chemotaxis of platelet ac-
tivating factor–stimulated rat PMN (Werr et al., 1998).
We reported previously (Loike et al., 1995) that differ-
ent chemoattractants specify qualitatively distinct PMN
responses when PMN contact specific matrix proteins. For
example, PMN stimulated with formyl methionyl leucyl
phenylalanine (fMLP) or tumor necrosis factor-
 
a
 
 form
zones of close apposition on fibrin and do not migrate
through fibrin gels, whereas PMN stimulated with leuko-
triene B4 (LTB4) or interleukin 8 (IL-8) form zones of
loose apposition on fibrin and migrate efficiently into and
through fibrin gels (Loike et al., 1995). All of these che-
moattractants activate PMN 
 
b
 
2
 
 integrins (Diamond and
Springer, 1994; Premack and Schall, 1996) and induce
PMN to migrate efficiently through three-dimensional ma-
trices composed of Matrigel or collagen I (Loike et al.,
1995). Antibodies that block the ligand-binding domains
of 
 
b
 
2
 
 integrins inhibit PMN migration through all matrices
tested (i.e., collagen I, Matrigel, and fibrin), in response to
chemoattractants. Therefore, it seemed unlikely that the
different effects of fMLP and LTB4 on PMN chemotaxis
through fibrin gels could result from small differences in
the effects of these chemoattractants on 
 
b
 
2
 
 integrins.
 
b
 
1
 
 integrins regulate the activity of 
 
a
 
M
 
b
 
2
 
 integrins on
PMN (Brown, 1992) and monocytes (Pommier et al., 1983;
Wright et al., 1984), and of 
 
a
 
III
 
b
 
3
 
 integrins on platelets
(Loike et al., 1993). We reasoned that fMLP, but not
LTB4, might activate one or more PMN 
 
b
 
1
 
 integrins and
that signals generated by the interaction of activated 
 
b
 
1
 
 in-
tegrins with ligands on fibrin might affect PMN chemo-
taxis. To test this hypothesis we examined the effects of
fMLP and LTB4 on activation of PMN 
 
b
 
1
 
 integrins, and of
antibodies and peptides that block 
 
b
 
1
 
 integrins on fMLP-
and LTB4-stimulated PMN adhesion to and migration
through fibrin gels. We report here that fMLP, but not
LTB4, activates 
 
b
 
1
 
 integrins on PMN, and that the inter-
action of activated 
 
b
 
1
 
 integrins with fibrin alters the qual-
ity of 
 
b
 
2
 
 integrin–dependent adhesion to, and migration
through, fibrin gels.
 
Materials and Methods
 
Reagents
 
Rhodamine-conjugated polyethylene glycols of 3.5 kD (Rh-PEG 3.5 kD)
and 10 kD (Rh-PEG 10 kD) were prepared as described (Loike et al.,
1993, 1995). Sources of antibodies and peptides were as follows: mouse
anti-
 
b
 
1
 
 (P4C10) and the peptides GRGDSP and GRGESP were from
GIBCO BRL. Mouse anti–human 
 
a
 
x
 
 (LeuM5) was from Organon-
Teknika Inc. Mouse anti–human 
 
a
 
M
 
b
 
2
 
 (MAC-1) was from Upstate Bio-
technology Co. Mouse anti–human 
 
a
 
5 
 
(SAM1), rat anti–human 
 
a
 
6
 
(GoH3), mouse anti–human 
 
a
 
4
 
 (HP2/1), and mouse anti–human 
 
b
 
3
 
 inte-
grin (SZ21) were from Immunotech. Phycoerythrin-conjugated F(ab)
 
2
 
anti–mouse IgG was from Jackson ImmunoResearch. Mouse anti-
 
b
 
3
 
(PPM6/13) was from Biosource International. Mouse anti-
 
b
 
3 
 
(MAB1957z)
was from Chemicon International. Alexa 488–conjugated F(ab)
 
2
 
 anti–
mouse IgG was from Molecular Probes. LTB4, fMLP, PMA, thrombin,
and Ficoll-Hypaque were from Sigma Chemical Co. Mouse anti–chicken
 
b
 
1
 
 integrin (CSAT) and mouse monoclonal anti–human 
 
b
 
1
 
 integrin
(AiiB2) were generous gifts from Dr. Clayton Buck (University of Cali-
fornia, San Francisco, CA). Mouse mAb 15/7, which recognizes an activa-
 
tion epitope on human 
 
b
 
1
 
 integrins (Bohnsack et al., 1995), was from
Athena Neurosciences. Mouse mAb IB4, which blocks the ligand-binding
domains of human 
 
b
 
2
 
 integrins (Wright et al., 1983), was a generous gift
from Dr. Samuel D. Wright (Merck, Rahway, NJ). PPACK was from Cal-
biochem-Novabiochem, Matrigel from Becton Dickinson, and collagen I
from GIBCO BRL. Purified fibronectin was from Vitex International. Fi-
brinogen was from American Diagnostica Inc. Fibrinogen uncontami-
nated by Factor XIII, fibronectin, and vitronectin, a generous gift of Dr.
Jeffrey Weitz (MacMaster University, Hamilton, Ontario, Canada), was
prepared from fibrinogen obtained from Enzyme Research Labs FIBI. It
was first adsorbed with gelatin-agarose to remove fibronectin and then
passed over an affinity column to remove Factor XIII. The fibrinogen was
precipitated with 25% ammonium sulfate, dialyzed against 150 mM NaCl,
20 mM Tris (pH 7.4), adsorbed with an antibody to human vitronectin
linked to Affi-gel, and dialyzed. PAGE analysis showed the resulting fi-
brinogen to be free of fibronectin or Factor XIII. Western blot analysis re-
vealed no vitronectin (data not shown).
 
Preparation of Boyden-type Chemotaxis Chambers
 
Gels, 
 
z
 
1 mm thick, composed of fibrin, Matrigel, or collagen type IV,
were formed in cell culture inserts (pore sizes 3 or 8 
 
m
 
m) from Becton
Dickinson as described (Loike et al., 1995). Fibrin gels were gently
washed with PBS to remove any residual PPACK.
 
PMN Adhesion and Closeness of Apposition to
Fibrin-coated Surfaces
 
Fibrin/fibrinogen-coated surfaces were prepared as described (Wright et al.,
1988; Loike et al., 1992, 1993, 1995) and PMN adhesion was measured by
phase-contrast microscopy. Close apposition of PMN to fibrin/fibrinogen-
coated surfaces was defined as exclusion of Rh-PEG 10 kD from zones of
contact between PMN and fibrin/fibrinogen measured by fluorescence mi-
croscopy as described (Loike et al., 1993).
 
PMN Migration
 
PMN were prepared as described (Wright et al., 1988) from fresh heparin-
ized blood from healthy adult donors after informed consent. PMN used
in these experiments were 
 
.
 
95% pure as determined by Wright-Giemsa
staining (Wright et al., 1988). 10
 
6
 
 PMN in 100 
 
m
 
l of PBS supplemented
with 5.5 mM glucose and 0.1% human serum albumin (PBSG-HSA) were
placed in the upper compartment of each insert and incubated for 0–6 h at
37
 
8
 
C in a humidified atmosphere containing 95% air/5% CO
 
2
 
. At the
times and concentrations specified, chemoattractants, antibodies, and/or
peptides were added to the top and/or bottom compartments in 500 
 
m
 
l of
PBSG-HSA. At the end of incubations, chambers were shaken to dislodge
PMN from the lower surface of the inserts. The medium in each lower
compartment was collected and its content of PMN was determined using
a Coulter counter (Loike et al., 1995). Unless otherwise indicated, all val-
ues reported are the average of six different samples from at least three in-
dependent experiments.
 
Flow Cytometric Analysis
 
PMN (10
 
5
 
 cells/200 
 
m
 
l of PBSG-HSA) were incubated in suspension at
37
 
8
 
C for 30 min in the presence or absence of fMLP (10
 
2
 
7
 
 M) or LTB4
(10
 
2
 
7
 
 M), transferred to 96-well polystyrene tissue culture microtiter
plates (Corning), incubated for 30 min at 4
 
8
 
C in 200 
 
m
 
l PBSG-HSA con-
taining the indicated primary antibody (2 
 
m
 
g/ml), washed three times with
PBSG-HSA at 4
 
8
 
C, further incubated for 30 min at 4
 
8
 
C with either Alexa
488–conjugated or phycoerythrin-conjugated rabbit anti–mouse F(ab
 
9
 
)
 
2
 
 in
200 
 
m
 
l of PBSG-HSA, washed three times again with PBSG-HSA at 4
 
8
 
C,
and resuspended at 4
 
8
 
C in 300 
 
m
 
l PBS containing 2% BSA and 0.3 mg/ml
propidium iodide to determine cell viability. The contribution of dead
cells (usually 
 
,
 
2%) was removed from the final data analysis. The mean
fluorescence intensity of 3–5 
 
3
 
 10
 
3
 
 cells was determined using a Becton
Dickinson FACSCalibur
 
®
 
.
 
Results
 
PMN Chemotaxis through Matrigel and Fibrin Gels
 
PMN chemotax through three-dimensional gels composed 
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of reconstituted basement membrane proteins containing
collagen IV, laminin, and fibronectin (Matrigel; Fig. 1), or
collagen I (Loike et al., 1995) in response to a gradient of
fMLP or LTB4. In contrast, PMN chemotaxis through fi-
brin gels or plasma clots is dependent upon the specific
chemoattractant used. fMLP-stimulated PMN do not mi-
grate through fibrin gels or plasma clots, whereas LTB4-
stimulated PMN do (Fig. 2 A; Loike et al., 1995). Check-
erboard analyses confirmed that PMN migrate through
these gels in response to a chemoattractant gradient (Loike
et al., 1995). Placement of equimolar concentrations of
both fMLP and LTB4 into the bottom chambers inhibited
PMN from migrating through fibrin gels (Fig. 2 A; Loike
et al., 1995), confirming that fMLP’s effect is dominant
over LTB4’s effect.
Commercial fibrinogen contains small amounts of fi-
bronectin and vitronectin. To test whether matrix compo-
nents other than fibrin are responsible for inhibiting mi-
gration of fMLP-stimulated PMN through fibrin gels and
plasma clots, we performed additional experiments using
fibrin gels formed from purified fibrinogen that con-
tained no detectable fibronectin, plasminogen, Factor
XIII, or vitronectin. PMN stimulated with LTB4, but not
with fMLP, migrated through gels formed from purified
fibrinogen (Fig. 2 B). Moreover, collagen I gels (60 
 
m
 
g/
insert) each containing 10 mg of purified fibronectin did
not affect the migration of either fMLP- or LTB4-stimu-
lated PMN, whereas the addition of fibrinogen to such
gels blocked migration of fMLP-stimulated PMN (data not
shown). These results are consistent with reports (Asakura
et al., 1997; Farrell and al-Mondhiry, 1997; Suehiro et al.,
1997; Miettinen et al., 1998) that fibrin(ogen) contains se-
quences that are ligands for b1 integrins, and confirm that
fibrin is the matrix component that inhibits migration of
fMLP-stimulated PMN.
Effects of Antibodies against b1 and b2 Integrins on 
PMN Chemotaxis through Fibrin Gels and Matrigel
To examine the roles of b1 and b2 integrins in PMN migra-
tion through Matrigel (Fig. 1), or fibrin (Figs. 2 A and 3),
we added antibodies that block b1 or b2 integrins to the
upper compartment of Matrigel or fibrin-coated inserts to-
gether with PMN and measured the number of PMN that
migrated into the lower compartment in response to fMLP
or LTB4. As expected, mAb IB4, directed against b2 in-
tegrins (Wright et al., 1983), blocked PMN migration
through Matrigel (Fig. 1) or fibrin gels (Fig. 2 A) in re-
sponse to LTB4. Antibody IB4 also blocked fMLP-stimu-
lated PMN migration through Matrigel (Fig. 1), and did
not alter fMLP’s inhibitory effect on PMN chemotaxis
through fibrin gels (data not shown). These results are
consistent with previous reports (Diamond and Springer,
1994; Springer, 1995; Premack and Schall, 1996) that anti–
b2 integrin antibodies block PMN migration through en-
dothelia and through gels formed by a variety of extracel-
lular matrix proteins.
In contrast, mAbs AiiB2 (Bohnsack et al., 1990) and
P4C10 (Carter et al., 1990), which block the common b
chain of b1 integrins (CD29), had no effect on fMLP- or
LTB4-stimulated chemotaxis through Matrigel (Fig. 1), or
on LTB4-stimulated PMN migration through fibrin gels
Figure 1. Effects of mAbs against b1 and b2 integrins on PMN
chemotaxis through inserts precoated with Matrigel. 0.1 ml PBS
containing 22 mg of Matrigel was placed into each culture insert
(pore size 5 8 mm) and allowed to gel at room temperature for 24
h. 106 PMN in 250 ml PBSG-HSA were placed in the upper com-
partment of each insert. 1027 M LTB4 or 1027 M fMLP in 250 ml
of PBSG-HSA was added to the bottom compartment. Where in-
dicated, PMN were preincubated at 48C for 30 min in PBSG-
HSA containing 2 mg/ml of either anti-b1 or anti-b2 antibodies
before adding the cells to the upper compartment of the inserts.
Inserts were incubated for 6 h at 378C, at which time the medium
in each lower compartment was collected and its PMN content
was determined using a Coulter counter. Reported are the aver-
age number 6 SEM of PMN that migrated into the lower com-
partment from at least two samples in each of three independent
experiments.
Figure 2. LTB4 but not fMLP promotes PMN migration through
fibrin gels. Fibrin gels were prepared from commercial fibrinogen
(A) or from purified fibrinogen (B) and formed on top of filters
(8-mm pores) in tissue culture inserts as described in Materials
and Methods. 106 PMN were added to the upper chamber and 5 3
1028 M fMLP or 1027 M LTB4 was added to either the lower or
upper chamber as indicated. Where indicated, PMN were prein-
cubated with antibodies against b1 (AiiB2) or against a5b1
(SAM1) integrins at 2 mg/ml for 30 min at 48C and the mixture
was added to the upper chamber. Inserts were incubated at 378C
for 6 h, at which time the number of cells in the lower chamber
was determined using a Coulter counter.The Journal of Cell Biology, Volume 144, 1999 1050
(Fig. 2 A). However, these same anti–b1 chain antibodies
reversed fMLP’s inhibitory effect on PMN chemotaxis
through fibrin (Fig. 3 A).
Control experiments showed that CSAT (Lallier and
Bronner-Fraser, 1991), a mAb that binds to chicken but
not human b1 integrins, SZ21, an antibody against b3 inte-
grins (Lawson and Maxfield, 1995), and PM6/13, another
antibody against b3 integrins (Patel et al., 1998), did not
alter the inhibitory effect of fMLP on PMN migration
through fibrin gels (Fig. 3 A and data not shown). These
antibodies also did not affect migration of LTB4-stimu-
lated PMN through fibrin gels (data not shown).
Among the antibodies directed against the a chains of
b1 integrins, only those directed against a5 chains were ef-
fective in reversing fMLP’s inhibitory effect on PMN mi-
gration through fibrin gels (Figs. 2 B and 3 A). Neither an-
tibodies against a4 chains nor antibodies against a6 chains
of b1 integrins affected migration of fMLP- or LTB4-stim-
ulated PMN through fibrin gels (Fig. 3 A) or Matrigel (Fig.
3 B and data not shown).
To confirm that b1 integrins directly interact with fi-
brin(ogen), we examined the effects of anti–b1 integrins
on the migration of fMLP-stimulated PMN through gels
formed of purified fibrinogen, lacking detectable levels of
fibronectin, vitronectin, plasminogen, or Factor XIII. Both
antibodies directed against b1 and a5 chains of b1 integrins
(Fig. 2 B) reversed fMLP’s inhibitory effect on chemotaxis
through these gels. These results are consistent with re-
ports (Asakura et al., 1997; Farrell and al-Mondhiry,
1997; Suehiro et al., 1997; Miettinen et al., 1998) that fi-
brin(ogen) contains sequences that are ligands for b1 inte-
grins.
The peptide GRGDSP blocks the interaction of b1 inte-
grins with RGD ligands on matrix proteins (Pierschbacher
and Ruoslahti, 1987). Like antibodies against b1 integrins,
addition of GRGDSP peptide to the medium allowed
fMLP-stimulated PMN to migrate through fibrin gels
(Table I). Control experiments showed that GRGESP
peptide, which does not block binding of b1 integrins
to fibronectin or other RGD-containing matrix proteins
(Pierschbacher and Ruoslahti, 1987), did not reverse the
inhibitory effect of fMLP on PMN migration through fi-
brin gels (Table I). Neither peptide affected the number of
PMN that migrated through fibrin in response to LTB4
(Table I) or through Matrigel in response to fMLP (Fig. 3 B).
Effects of Antibodies against b1 and b2 Integrins
on Adhesion of Chemoattractant-stimulated PMN
to Fibrin
PMN were incubated in control medium or in medium
containing fMLP or LTB4 and allowed to adhere to fibrin-
coated 96-well plates. In the absence of chemoattractant
,1% PMN adhered to fibrin (data not shown). Over 40%
of fMLP-stimulated PMN and z50% of LTB4-stimulated
PMN adhered to fibrin. mAb IB4, which blocks the ligand-
binding sites of three different b2 integrins (aLb2, aMb2,
and aXb2; Wright et al., 1983; Loike et al., 1991), inhibited
adhesion of fMLP- or LTB4-stimulated PMN to fibrin by
75–80% (Fig. 4). In contrast, mAb AiiB2, which blocks the
ligand-binding sites of b1 integrins (Bohnsack et al., 1990),
had no significant effect on the number of fMLP-stim-
ulated PMN that adhered to fibrin, and enhanced by
z25% adhesion of LTB4-stimulated PMN to fibrin (Fig.
4). These experiments show that b2 integrins are the pri-
mary PMN surface receptors that mediate adhesion of
chemoattractant-stimulated PMN to fibrin.
fMLP, but Not LTB4, Activates PMN a5b1 Integrins
The findings presented above indicate that b1 integrins,
and specifically a5b1 integrins, mediate the qualitatively
distinct effects of fMLP and LTB4 on PMN adhesion to,
and migration through, fibrin gels. To determine whether
fMLP and LTB4 differentially affect the activation of b1
integrins we used mAb 15/7, which recognizes a confor-
Figure 3. Effects of anti–b1 and anti–b2 integrins on PMN
chemotaxis through fibrin-coated inserts or Matrigel-coated in-
serts. Inserts were prepared as described in Fig. 1. Where indi-
cated, PMN were preincubated for 30 min at 48C with 2 mg/ml of
one of the following mAbs: mouse anti-b1 (P4C10), mouse anti–
human a4 (HP2/1), mouse anti–human a5 (SAM1), or rat anti–
human a6 (GoH3), or with 1 mg/ml of GRGDSP peptide. The
mixture was then added to the upper compartment of fibrin-
coated inserts. 1027 M LTB4 or 5 3 1028 M fMLP was placed in
the lower compartment, and the inserts were incubated at 378C
for 6 h. The number of PMN in the lower compartment was as-
sayed as described in Fig. 1.
Table I. Effect of RGD-containing Peptides on fMLP- and 
LTB4-stimulated PMN Chemotaxis through Fibrin Gels
Additions Chemoattractant
PMN in lower
compartment (3 1023)
None fMLP 3 6 1
GRGDSP fMLP 50 6 5
GRGESP fMLP 2 6 1
None LTB4 135 6 30
GRGDSP LTB4 170 6 50
GRGESP LTB4 110 6 40
106 PMN were preincubated for 30 min at 4°C with PBSG-HSA alone or containing 1
mg/ml GRGDSP or GRDESP before adding the mixture to the upper compartment of
chemotaxis chambers. LTB4 (1027 M) or fMLP (1027 M) was added to the lower
compartment, the chambers were incubated at 37°C for 6 h, and the number of PMN
that migrated into the lower compartment was determined, all as described in Fig. 1.
Values represent the average 6 SEM of triplicate samples from three experiments.Loike et al. b1 Integrins Regulate PMN Chemotaxis 1051
mationally determined epitope on activated b1 integrins
(Bohnsack et al., 1995). PMN incubated for 30 min with
fMLP exhibited a 10–22-fold increase in binding of mAb
15/7 (Fig. 5 J), compared with unstimulated PMN (Fig. 5
B), whereas PMN incubated for the same length of time
with LTB4 (Fig. 5 F) showed little change over unstimu-
lated PMN (Fig. 5 B) with respect to binding of mAb 15/7.
Control experiments showed that surface expression of b1
integrins was stimulated approximately twofold by LTB4
(Fig. 5 G), and approximately threefold by fMLP (Fig. 5
K), whereas b2 integrin surface expression was stimulated
approximately fivefold by LTB4 (Fig. 5 H) and approxi-
mately ninefold by fMLP (Fig. 5 L). Other studies showed
that the extent of expression of the epitope for antibody
15/7 on b1 integrins was dependent upon the dose of fMLP
used to stimulate the PMN, and that 5 3 1026 M fMLP in-
duced maximal expression of this epitope (not shown). In
contrast, LTB4 concentrations 10–50-fold higher (i.e., 1026
to 5 3 1026 M) than those used in the experiments de-
scribed in Fig. 5 did not increase expression of the 15/7
epitope on b1 integrins (data not shown).
Effects of Antibodies against b1 Integrins on Closeness 
of Apposition of fMLP- and LTB4-stimulated PMN
to Fibrin
We have used exclusion of Rh-PEG 10 kD from zones of
contact between chemoattractant-stimulated PMN and fi-
brin-coated surfaces as a measure of the closeness of appo-
sition of PMN to the underlying substrate (Loike et al.,
1995). Previously, we reported an inverse correlation be-
tween the formation of zones of close apposition between
chemoattractant-stimulated PMN and fibrin gels and the
capacity of PMN to migrate through these gels (see Fig. 7
in Loike et al., 1995). In the present experiments we used
exclusion of Rh-PEG 10 kD to test whether antibodies
and peptides that block b1 integrins, and that facilitate mi-
gration of fMLP-stimulated PMN through fibrin gels (Figs.
2 and 3 A and Table I), affect the closeness of apposition
of these cells to fibrin. Antibodies against the b chain of b1
integrins, or against the a5 chain of a5b1 integrins (not
shown), reduced the percentage of fMLP-stimulated PMN
that excluded Rh-PEG 10 kD from zones of contact with
fibrin from 80% to 20–30% (Fig. 6), and reduced the per-
centage of LTB4-stimulated PMN that excluded Rh-PEG
10 kD from these contact zones from 20% to ,2% (Fig.
Figure 4. Effect of anti-b1 and anti-b2 antibodies on adhesion of
fMLP- or LTB4-stimulated PMN to fibrin-coated surfaces. 5 3
103 PMN in 5 ml PBSG-HSA containing 1027 M fMLP or 1027 M
LTB4 were allowed to settle for 30 min at 48C in the presence or
absence of the indicated antibody (10 mg/ml) onto each well of a
96-well plate that had been precoated with fibrin. Then, cells
were warmed to 378C for 15 min. The plates were washed, fixed,
and counted as described (Wright et al., 1988).
Figure 5. Effect of fMLP and
LTB4 on activation of PMN b1
integrins. Fluorescence intensity
of PMN incubated as described
in Materials and Methods with
Alexa 488–conjugated rabbit
F(ab9)2 anti–mouse IgG alone
(A, E, and I), with mAb 15/7
that recognizes an activation epi-
tope on b1 integrins followed by
Alexa 488–conjugated F(ab9)2
anti–mouse IgG (B, F, and J),
with mAb CD29 that recognizes
the b chain of human b1 inte-
grins followed by Alexa 488–
conjugated F(ab9)2 anti–mouse
IgG (C, G, and K), or with a mAb
that recognizes aMb2 (CD11b/
CD18) followed by Alexa
488–conjugated rabbit F(ab9)2
anti–mouse IgG (D, H, and L).
Unstimulated PMN (A–D),
LTB4-stimulated PMN (E–H),
fMLP-stimulated PMN (I–L).
fMLP and LTB4 were each used
at 1027 M.The Journal of Cell Biology, Volume 144, 1999 1052
6). These experiments together with those shown in Fig. 5
show there is a direct correlation between the capacity of
fMLP or LTB4 to activate PMN b1 integrins and the ca-
pacity of these chemoattractants to promote close apposi-
tion between PMN and fibrin (as measured by exclusion of
Rh-PEG 10 kD), and to inhibit PMN migration through fi-
brin gels (Fig. 3 A).
Effects of Phorbol Esters on PMN Adhesion
and Migration
Tumor-promoting phorbol esters, like ligands that bind to
PMN and macrophage fibronectin receptors, activate aMb2
(CD11b/CD18) for phagocytosis of C3bi-coated particles
(Wright and Silverstein, 1982), and promote formation of
zones of close apposition between phorbol ester–stimu-
lated PMN and fibrinogen-coated surfaces (Table II).
However, phorbol ester–stimulated PMN do not migrate
into fibrin gels, even when treated with antibodies against
a5b1 integrins (data not shown). These findings suggested
that phorbol esters activate aMb2 integrins for close appo-
sition to fibrin independently of b1 integrins. To test this
prediction, PMN were incubated with or without antibod-
ies against b1 integrins, allowed to adhere to fibrin- or fi-
brinogen-coated surfaces in medium containing PMA, and
then were incubated with Rh-PEG 10 kD. 77% of PMA-
treated PMN formed zones of close apposition on fibrin
even when they had been treated with antibodies against
b1 integrins. In contrast, ,15% of the PMA-stimulated
PMN that adhered to these surfaces formed zones of close
apposition when treated with antibodies against b2 inte-
grins (Table II). This experiment shows that when suitably
activated, b2 integrins are capable of mediating close ap-
position between PMN and fibrin-coated surfaces in the
absence of b1 integrin ligation.
Discussion
The different effects of fMLP and LTB4 on PMN adhe-
sion to and chemotaxis through fibrin gels appear to be a
consequence of qualitative differences in the effects of
these chemoattractants on the activity of b1 integrins. That
is, fMLP activates b1 integrins (Fig. 5 and Table III), stim-
ulates PMN to adhere closely to fibrin(ogen) (Fig. 6 and
Table III; Loike et al., 1995), and inhibits PMN chemo-
taxis through fibrin gels (Fig. 2 and Table III; Loike et al.,
1995). In contrast, LTB4 neither activates b1 integrins
(Fig. 5 and Table III) nor induces PMN to adhere closely
to fibrin(ogen) (Fig. 6 and Table III; Loike et al., 1995),
and stimulates PMN to migrate through fibrin gels (Fig. 2
and Table III; Loike et al., 1995). To our knowledge, this is
the first demonstration that signals initiated by two chemi-
cally distinct chemoattractants with their respective seven
membrane spanning/heterotrimeric G protein–coupled re-
ceptors exert different effects on the activation state of a
specific b1 integrin, and regulate PMN migration.
Fibrin(ogen)-containing Matrices Exert a
Specific Effect
As shown in Fig. 2, fibrin(ogen) is unique among the ma-
trix and plasma proteins tested in arresting the migration
of fMLP-stimulated PMN. This is particularly notable in
the case of fibronectin, a well-recognized ligand for a5b1
integrins. The failure of fibronectin to induce migration
arrest suggests that fibrin(ogen) has heretofore unrecog-
nized properties, independent of its ability to bind a5b1 in-
tegrins, that are important in its ability to cause migration
arrest.
Relationship between Closeness of Apposition, 
Tightness of Adhesion, and Cell Migration
DiMilla et al. (1993) and Palecek et al. (1997) reported
Figure 6. Effect of anti–b1 integrin antibodies on formation of
zones of close apposition between PMN and fibrin-coated sur-
faces. 5 3 103 PMN in 30 ml PBSG-HSA containing 1027 M
fMLP, or 1027 M LTB4, were allowed to adhere to each fibrin-
coated spot of multispot slides in the presence or absence of
P4C10 anti–b1 integrin antibody (2 mg/ml) for 30 min at 378C.
The preparations were further incubated at room temperature
for 30 min with either fluorescein-conjugated antifibrinogen IgG
(Loike et al., 1995), Rh-PEG 10 kD, or Rh-PEG 3.5 kD (Loike et
al., 1992, 1993, 1995) and examined by epifluorescence micros-
copy. A zone of close apposition is defined as a region between
adherent PMN and the underlying matrix from which fluoro-
phore-conjugated probe is excluded. Values are expressed as the
percentage of adherent PMN that forms such zones. Note that
Rh-PEG 3.5 kD stained the surfaces uniformly, confirming the
presence of fibrin underneath all adherent PMN and showing
that molecules of 3.5 kD penetrate zones of close apposition.
Table II. Effect of Antibodies against b1 or b2 Integrins on 
Formation of Zones of Close Apposition to Fibrin by
PMA-stimulated PMN
Additions
Percent of PMN forming zones of close apposition
Fibrin-coated surfaces Fibrinogen-coated surfaces
None 78 6 6 94 6 2
Anti-b1 77 6 3 95 6 1
Anti-b2 12 6 4 14 6 5
5 3 103 PMN stimulated with PMA (300 ng/ml) in 30 ml PBSG-HSA were allowed to
adhere to each fibrin- or fibrinogen-coated spot of multispot slides in the presence or
absence of P4C10 anti–b1 integrin antibody (2 mg/ml) for 30 min at 37°C. The prepa-
rations were further incubated at room temperature for 30 min with Rh-PEG 10 kD,
and examined by epifluorescence microscopy. A zone of close apposition is defined as
described in Fig. 6. Values represent the average 6 SEM of triplicate samples from
three experiments.Loike et al. b1 Integrins Regulate PMN Chemotaxis 1053
that smooth muscle cells migrate optimally on fibronectin-
coated surfaces when their integrins bind to these surfaces
at intermediate strengths. Weber et al. (1996) reported an
inverse correlation between the strength of adhesion of
chemokine-stimulated monocytes to surfaces coated with
the 120-kD RGD-containing fibronectin fragment and the
capacity of these cells to migrate across filters coated with
this fibronectin fragment. The findings of Keller et al.
(1979) and of Wilkinson et al. (1984), and those reported
in Fig. 6, demonstrate an inverse correlation between
closeness of apposition of PMN to surfaces coated with
proteins that express ligands for PMN receptors and the
ability of PMN to migrate on or through matrices contain-
ing these proteins. Thus, it seems likely that loose versus
close apposition between cells and matrix protein–coated
substrates reflects weak versus strong adhesion, respec-
tively, between the cells and the substrate.
PMA Bypasses b1 Integrins in Stimulating PMN to 
Adhere Closely to Fibrin
Antibodies against b2 integrins reduced adhesion, inhib-
ited close apposition between PMA-stimulated PMN and
fibrin (Table II), and blocked PMN migration through fi-
brin (data not shown). Antibodies against b1 integrins had
no effect on any of these parameters (Table II and data
not shown). These results demonstrate that the interaction
of activated b2 integrins with fibrin is both required and
sufficient for PMA-stimulated PMN to form zones of close
apposition on fibrin (Table II), and that PMA bypasses the
requirement for engagement of activated b1 integrins by
matrix proteins for PMN to form zones of close apposition
on fibrin.
Pathways by Which fMLP and LTB4 Activate 
b1 and b2 Integrins
Although the signal transduction pathways by which che-
moattractants regulate PMN b1 and b2 integrins remain to
be elucidated, our findings lead us to make three sugges-
tions regarding the organization of these pathways.
First, antibodies that activate b1 integrins do not pro-
mote adhesion of unstimulated PMN to fibrin, or inhibit
LTB4-stimulated chemotaxis of PMN through fibrin gels
(unpublished data). These results suggest that signals initi-
ated by both fMLP receptors and activated b1 integrins are
required to inhibit chemotaxis of fMLP-stimulated PMN
through fibrin gels.
Second, the finding that fMLP and PMA have similar ef-
fects on PMN adhesion to and migration through fibrin
gels might suggest that the interaction of activated b1 inte-
grins of fMLP-stimulated PMN with fibrin activates pro-
tein kinase C, and that this is the mechanism by which
fMLP signals b2 integrins to bind closely to fibrin. How-
ever, Laudanna et al. (1996) reported that calphostin C, a
protein kinase C inhibitor, blocks adhesion of PMA-stimu-
lated, but not of fMLP-stimulated, mouse lymphocytes
transfected with fMLP receptors, to VCAM-1–coated
surfaces. (Adhesion of chemokine-stimulated lympho-
cytes to VCAM-1 is mediated by activated a4b1 integrins.)
Laudanna et al. (1996) identified rho as a key participant
in fMLP- and IL-8–mediated activation of a4b1 integrins in
mouse lymphocytes. This finding suggests to us that rho
acts downstream of Gai in activating b1 integrins. The re-
port of Caron and Hall (1998) that rho participates in cou-
pling CR3 (CD11b/CD18) to the actin cytoskeleton sug-
gests that rho also affects b2 integrin–mediated functions.
Whether PMN LTB4 receptors activate rho is unknown
and should be investigated.
Third, binding of fMLP to its receptor activates Gai
(Laudanna et al., 1996). The specific Ga activated by
LTB4 in PMN has not been reported. Pertussis toxin,
which inactivates Gai, blocks most effects of LTB4 and of
fMLP on human PMN. Thus, the finding that fMLP acti-
vates b1 integrins (Fig. 5 J) while LTB4 does not (Fig. 5 F)
suggests that binding of LTB4 to its receptor activates Ga
subunits other than, or in addition to, Gai and that this dif-
ference in Ga subunit utilization is responsible for the di-
vergent effects of fMLP and LTB4 on b1 integrin activa-
tion (Fig. 5), and on closeness of PMN adhesion to fibrin
(Fig. 6). Indeed, Arai and Charo (1996) have shown differ-
ential utilization of Ga subunits after MCP-1 or IL-8 stim-
ulation of MCP-1 or IL-8 receptor transfected HEK293
cells, and Yokomizo et al. (1997) have demonstrated that
pertussis toxin treatment does not ablate Ca21 increases
stimulated by LTB4 in LTB4 receptor-bearing CHO cells.
Proposed Mechanisms by Which fMLP Inhibits PMN 
Chemotaxis through Fibrin Gels
Our studies suggest at least three distinct mechanisms by
which fMLP could inhibit PMN migration through fibrin
gels. First, the combined strengths of adhesion of activated
b1 and b2 integrins to fibrin could be sufficient to immobi-
lize PMN on fibrin. Our unpublished finding that antibod-
ies that activate b1 integrins do not inhibit migration of
LTB4-stimulated PMN through fibrin gels casts doubt on
this combined-strength-of-adhesion hypothesis as an ex-
Table III. Summary of Results
Chemoattractant*
Assay mAb  added:
fMLP LTB4
None None Anti-b1 Anti-b2 None Anti-b1 Anti-b2
Adhesion to fibrin* .40% .40% ,10% z50% z66% ,10% ,5%
Chemotaxis 212112 2
Exclusion Rh-PEG (10 kD) 80% 20% ,5% 20% 2% ,5% ,5%
Binding mAb 15/7 z103 ND ND bkg ND ND bkg
bkg
*Percent of control. About 40% and 60% of the added PMN adhered to the fibrin-coated surfaces in response to fMLP and LTB4, respectively. ND, not done; bkg, background.The Journal of Cell Biology, Volume 144, 1999 1054
planation for the inhibitory effect of fMLP on PMN che-
motaxis through fibrin.
Second is the possibility that binding of fMLP or LTB4
to its cognate receptors directly and differentially activates
b2 integrins for strong or weak adhesion, respectively. Ac-
cording to this hypothesis, fMLP-activated b1 integrins
play no role in inhibiting chemotaxis of fMLP-stimulated
PMN through fibrin. However, since activated b1 integrins
mediate outside-in signaling, RGD peptides and antibod-
ies against b1 integrins reverse fMLP’s inhibitory effect on
PMN migration through fibrin by stimulating b1 integrins
to signal trans-dominant negative (Diaz-Gonzalez et al.,
1996) effects on b2 integrins. Against this hypothesis are
the findings that antibodies against the a6 chains of b1 inte-
grins (Fig. 3), and antibodies that activate b1 integrins (un-
published data), do not reverse fMLP’s inhibitory effect
on PMN chemotaxis through fibrin.
Third, and we think most likely, is that the capacity of
fMLP to promote close adhesion to, and to block migra-
tion through, fibrin gels is mediated by a cascade of signals
(diagrammed in Fig. 7), in which the interaction of acti-
vated b1 integrins with the fibrin matrix causes trans-dom-
inant activation of b2 integrins. This mechanism is consis-
tent with previous studies (Pommier et al., 1983; Wright et
al., 1984; Brown, 1992) showing that interaction of PMN
or macrophages with RGD-containing matrix proteins ac-
tivates aMb2 integrins for phagocytosis of C3bi-coated par-
ticles.
As shown in Fig. 7, we suggest that the interaction of
LTB4 or fMLP with their respective PMN receptors gen-
erates a “common” signal that activates b2 integrins for
loose adhesion to fibrin (Fig. 7, A and B, and D and E, re-
spectively). In addition, we propose that fMLP receptors
(Fig. 7 C) also signal activation of a5b1 integrins (Figs. 5 J
and 7 E). We further suggest that binding of activated a5b1
integrins to fibrin matrices clusters these integrins, thereby
generating an outside-in signal that activates b2 integrins
(Fig. 7 F), for close apposition between PMN and fibrin-
coated substrates (Fig. 7 G).
Close apposition reflects tight adhesion (Keller et al.,
1979; Wilkinson et al., 1984; DiMilla et al., 1993; Palecek
et al., 1997), presumably mediated by the coupling of b2 in-
tegrins to the cytoskeleton. We do not know whether tight
adhesion causes, or is merely associated with, cessation of
migration. In either case, PMN cease migrating (Figs. 2 A
and 3 A, and Table III). We propose that antibodies and
peptides that block the interaction of activated a5b1 inte-
grins with fibrin (Figs. 2 and 3, and Table I) inhibit these
outside-in signals, thereby blocking trans-dominant activa-
tion of b2 integrins for close apposition to fibrin (Fig. 6 and
Table II) and allowing PMN to migrate through fibrin.
The interaction of LTB4 with its receptor also generates
a signal that stimulates b2 integrins for loose apposition.
However, LTB4 does not activate b1 integrins (Fig. 5 F).
Therefore, these b1 integrins do not bind to the matrix, do
not generate outside-in signals, and therefore do not ini-
tiate trans-dominant activation of b2 integrins for close ap-
position (Fig. 7, A–C), or cessation of migration.
What Characterizes the Sessile State?
Further work is needed to determine whether cessation of
migration is merely a function of strong adhesion between
PMN and fibrin or whether it reflects reorganization of the
PMN cytoskeleton as observed by Dustin et al. (1997) in
antigen-sensitized T lymphocytes. They found that these
cells become immobilized when they encounter MHC
class II molecules containing a peptide antigen recognized
by the T lymphocytes’ antigen receptors. They identified
changes in microtubule organization of these sessile T
lymphocytes that distinguish them from their randomly
migrating brethren. We suspect that PMN that adhere to
fibrin after fMLP stimulation will exhibit similar changes
in cytoskeletal organization.
Why Are There So Many Different Chemoattractants 
for PMN?
Our findings suggest that the availability of many different
chemoattractants (e.g., fMLP, LTB4, IL-8, C5a, etc.)
serves two complementary functions. First, they provide
redundancy, thereby assuring that pathogenic microbes
are detected rapidly by the innate immune system. Sec-
ond, they reflect the need to direct PMN to different tissue
sites and to prepare them for interactions with many dif-
ferent types of ligands.
Chemoattractant-encrypted Stop Signals Provide a 
Gradient-independent Mechanism for Leukocyte 
Accumulation at Specific Anatomic Sites
Our findings also suggest an alternative to the notion that
leukocyte accumulation at a specific anatomic site in vivo
requires the presence of a gradient of chemoattractant/
chemokine emanating from that site. While there is no
doubt that gradients of chemoattractants/chemokines are
formed in vitro (Keller et al., 1979; Wilkinson et al., 1984;
Huber et al., 1991; Campbell et al., 1996, 1997; Foxman et al.,
1997; Palecek et al., 1997), they may be difficult to main-
tain in vivo in the face of the perturbing effects of muscu-
lar contraction and variations in blood and lymph flow.
Leukocytes in the vascular system begin to enter specific
Figure 7. Proposed mechanism by which fMLP and LTB4 regu-
late b1 and b2 integrins, and thereby regulate PMN chemotaxis
through fibrin gels. See Discussion for description.Loike et al. b1 Integrins Regulate PMN Chemotaxis 1055
tissue compartments when they encounter a chemoattrac-
tant/chemokine. We suggest that once within this tissue
compartment leukocytes migrate randomly in response to
a relatively uniform concentration of matrix-bound che-
moattractant/chemokine. When in the course of this ran-
dom walk they encounter extracellular matrix proteins or
cells that express ligands for a specific activated b1 inte-
grin, they adhere strongly and become sessile. By regulat-
ing activation of specific receptors and adhesive strengths,
concentrations of chemoattractants/chemokines well be-
low those required to saturate or desensitize chemoattrac-
tant/chemokine receptors can mediate a stochastic process
by which leukocytes accumulate at specific anatomic sites
and form highly ordered structures (e.g., granulomas, ger-
minal centers). According to this model, leukocytes accu-
mulate at specific anatomic sites by a process that is simi-
lar in principle to the accumulation of flies on fly paper.
Foxman et al. (1997) showed that multiple chemoattrac-
tants/chemokines can work in combination to elicit mi-
gration patterns that cannot be achieved by a single che-
moattractant/chemokine. The mechanisms we and they
have described are complementary. These mechanisms are
likely to be of special importance within tissue compart-
ments where overlapping fields of chemoattractants/che-
mokines/cytokines surely occur, and where cells migrate in
stepwise fashion from one anatomic site to another (e.g.,
T cell movement in lymph nodes from T cell–rich paracor-
tical zones to germinal centers; Garside et al., 1998), PMN
accumulation at foci of bacterial infection, or of immune-
complex deposition (Wilkinson et al., 1984). The essential
point of the findings reported here is that by endowing
leukocytes, and probably all migrating cells, with a modest
number of receptors for different chemoattractants, che-
mokines, and cytokines, nature has made optimal use of
instructive and selective mechanisms to achieve a level of
organizational specificity that would otherwise require
substantially more genetic information.
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